Izunna Okeke

Array ( [id] => 2635111 [patent_doc_number] => 04952674 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1990-08-28 [patent_title] => 'Vaccine against varicella-zoster virus' [patent_app_type] => 1 [patent_app_number] => 6/859159 [patent_app_country] => US [patent_app_date] => 1986-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4693 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/952/04952674.pdf [firstpage_image] =>[orig_patent_app_number] => 859159 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2623000 [patent_doc_number] => 04919930 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1990-04-24 [patent_title] => 'Synthetic M proteins-streptococci type 5' [patent_app_type] => 1 [patent_app_number] => 6/858436 [patent_app_country] => US [patent_app_date] => 1986-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8401 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/919/04919930.pdf [firstpage_image] =>[orig_patent_app_number] => 858436 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2444158 [patent_doc_number] => 04745101 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1988-05-17 [patent_title] => 'Novel peptide having dentinal fluid transport-stimulating activity' [patent_app_type] => 1 [patent_app_number] => 6/856021 [patent_app_country] => US [patent_app_date] => 1986-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4600 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/745/04745101.pdf [firstpage_image] =>[orig_patent_app_number] => 856021 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2384132 [patent_doc_number] => 04783442 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1988-11-08 [patent_title] => 'B-cell differentiating peptides' [patent_app_type] => 1 [patent_app_number] => 6/855011 [patent_app_country] => US [patent_app_date] => 1986-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5310 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/783/04783442.pdf [firstpage_image] =>[orig_patent_app_number] => 855011 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2477825 [patent_doc_number] => 04822606 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1989-04-18 [patent_title] => 'Immunosuppressive synthetic peptides and analogs thereof based on retroviral envelope sequences' [patent_app_type] => 1 [patent_app_number] => 6/848469 [patent_app_country] => US [patent_app_date] => 1986-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 10154 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/822/04822606.pdf [firstpage_image] =>[orig_patent_app_number] => 848469 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2419330 [patent_doc_number] => 04727062 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1988-02-23 [patent_title] => '3-Halovinylglycine antibacterial agents' [patent_app_type] => 1 [patent_app_number] => 6/840254 [patent_app_country] => US [patent_app_date] => 1986-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6315 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/727/04727062.pdf [firstpage_image] =>[orig_patent_app_number] => 840254 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2415488 [patent_doc_number] => 04743679 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1988-05-10 [patent_title] => 'Process for producing human epidermal growth factor and analogs thereof' [patent_app_type] => 1 [patent_app_number] => 6/832337 [patent_app_country] => US [patent_app_date] => 1986-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6984 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 146 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/743/04743679.pdf [firstpage_image] =>[orig_patent_app_number] => 832337 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2444762 [patent_doc_number] => 04755380 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1988-07-05 [patent_title] => 'Peptide from amyloid A and antiserum therefor' [patent_app_type] => 1 [patent_app_number] => 6/826551 [patent_app_country] => US [patent_app_date] => 1986-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 855 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/755/04755380.pdf [firstpage_image] =>[orig_patent_app_number] => 826551 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2481754 [patent_doc_number] => 04882419 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1989-11-21 [patent_title] => 'Process for preparing antibiotic L 17392 (deglucoteicoplanin)' [patent_app_type] => 1 [patent_app_number] => 6/845268 [patent_app_country] => US [patent_app_date] => 1986-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7264 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 571 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/882/04882419.pdf [firstpage_image] =>[orig_patent_app_number] => 845268 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2361503 [patent_doc_number] => 04683221 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1987-07-28 [patent_title] => 'Lymphocyte-activating polypeptides' [patent_app_type] => 1 [patent_app_number] => 6/817526 [patent_app_country] => US [patent_app_date] => 1986-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7057 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 187 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/683/04683221.pdf [firstpage_image] =>[orig_patent_app_number] => 817526 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2441739 [patent_doc_number] => 04756908 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1988-07-12 [patent_title] => 'Method for the commercial production of helminths antigens' [patent_app_type] => 1 [patent_app_number] => 6/743877 [patent_app_country] => US [patent_app_date] => 1985-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2998 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/756/04756908.pdf [firstpage_image] =>[orig_patent_app_number] => 743877 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2445664 [patent_doc_number] => 04745179 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1988-05-17 [patent_title] => '.sup.59 Valine insulin-like growth factor I and process for production thereof' [patent_app_type] => 1 [patent_app_number] => 6/713828 [patent_app_country] => US [patent_app_date] => 1985-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13028 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/745/04745179.pdf [firstpage_image] =>[orig_patent_app_number] => 713828 [rel_patent_id] =>[rel_patent_doc_number] =>)